File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Surgical treatment of age-related macular degeneration: Will there be a role in the future?

TitleSurgical treatment of age-related macular degeneration: Will there be a role in the future?
Authors
KeywordsAMD
Maculatrans location
Surgery
Issue Date2007
PublisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/CEO
Citation
Clinical And Experimental Ophthalmology, 2007, v. 35 n. 2, p. 167-173 How to Cite?
AbstractSurgical treatment has been shown to be able to improve vision that is lost as a result of age-related macular degeneration. Surgery is complex, such that improvement has always to be weighed against risk of complications. The availability of Ranibizumab and Bevacizumab is set to dramatically alter our management options. Surgical treatment will have a limited role to play in the next few years. © 2007 The Authors; Journal compilation © 2007 Royal Australian and New Zealand College of Ophthalmologists.
Persistent Identifierhttp://hdl.handle.net/10722/90370
ISSN
2015 Impact Factor: 2.546
2015 SCImago Journal Rankings: 1.335
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorWong, Den_HK
dc.contributor.authorDurnian, JMen_HK
dc.date.accessioned2010-09-06T10:09:26Z-
dc.date.available2010-09-06T10:09:26Z-
dc.date.issued2007en_HK
dc.identifier.citationClinical And Experimental Ophthalmology, 2007, v. 35 n. 2, p. 167-173en_HK
dc.identifier.issn1442-6404en_HK
dc.identifier.urihttp://hdl.handle.net/10722/90370-
dc.description.abstractSurgical treatment has been shown to be able to improve vision that is lost as a result of age-related macular degeneration. Surgery is complex, such that improvement has always to be weighed against risk of complications. The availability of Ranibizumab and Bevacizumab is set to dramatically alter our management options. Surgical treatment will have a limited role to play in the next few years. © 2007 The Authors; Journal compilation © 2007 Royal Australian and New Zealand College of Ophthalmologists.en_HK
dc.languageengen_HK
dc.publisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/CEOen_HK
dc.relation.ispartofClinical and Experimental Ophthalmologyen_HK
dc.rightsThe definitive version is available at www3.interscience.wiley.com-
dc.subjectAMDen_HK
dc.subjectMaculatrans locationen_HK
dc.subjectSurgeryen_HK
dc.subject.meshAntibodies, Monoclonal - therapeutic use-
dc.subject.meshCost of Illness-
dc.subject.meshMacular Degeneration - economics - etiology - surgery-
dc.subject.meshOphthalmologic Surgical Procedures - trends-
dc.subject.meshVascular Endothelial Growth Factor A - antagonists and inhibitors-
dc.titleSurgical treatment of age-related macular degeneration: Will there be a role in the future?en_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1442-6404&volume=35&issue=2&spage=167&epage=173&date=2007&atitle=Surgical+treatment+of+age-related+macular+degeneration:+will+there+be+a+role+in+the+future?en_HK
dc.identifier.emailWong, D: shdwong@hku.hken_HK
dc.identifier.authorityWong, D=rp00516en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1111/j.1442-9071.2006.01410.xen_HK
dc.identifier.pmid17362461-
dc.identifier.scopuseid_2-s2.0-33847789965en_HK
dc.identifier.hkuros136215en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-33847789965&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume35en_HK
dc.identifier.issue2en_HK
dc.identifier.spage167en_HK
dc.identifier.epage173en_HK
dc.identifier.isiWOS:000244741500014-
dc.publisher.placeAustraliaen_HK
dc.identifier.scopusauthoridWong, D=7401536078en_HK
dc.identifier.scopusauthoridDurnian, JM=23496169000en_HK
dc.identifier.citeulike1147167-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats